Back to User profile » Professor Howard Lee
Papers published by Professor Howard Lee:
A critical review of the United States regulatory pathways for determining the equivalence of efficacy between CT-P13 and original infliximab (Remicade®)
Kim S, Kim S, Lee H
Drug Design, Development and Therapy 2020, 14:2831-2840
Published Date: 17 July 2020
Failure mode and effects analysis drastically reduced potential risks in clinical trial conduct
Lee H, Lee H, Baik J, Kim HJ, Kim R
Drug Design, Development and Therapy 2017, 11:3035-3043
Published Date: 19 October 2017
New tablet formulation of tacrolimus with smaller interindividual variability may become a better treatment option than the conventional capsule formulation in organ transplant patients
Kim YK, Kim A, Park SJ, Lee H
Drug Design, Development and Therapy 2017, 11:2861-2869
Published Date: 28 September 2017
Determination of the starting dose in the first-in-human clinical trials with monoclonal antibodies: a systematic review of papers published between 1990 and 2013
Suh HY, Peck CC, Yu KS, Lee H
Drug Design, Development and Therapy 2016, 10:4005-4016
Published Date: 8 December 2016
Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjects
Yoon S, Shin D, Lee H, Jang IJ, Yu KS
Drug Design, Development and Therapy 2015, 9:5033-5049
Published Date: 31 August 2015
A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profiles
Chung H, Lee H, Han H, An H, Lim KS, Lee YJ, Cho JY, Yoon SH, Jang IJ, Yu KS
Drug Design, Development and Therapy 2015, 9:2609-2616
Published Date: 13 May 2015
A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects
Park SI, Lee H, Oh J, Lim KS, Jang IJ, Kim JA, Jung JH, Yu KS
Drug Design, Development and Therapy 2015, 9:729-736
Published Date: 4 February 2015
Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers
Lee J, Lee H, Jang K, Lim KS, Shin D, Yu KS
Drug Design, Development and Therapy 2014, 8:1781-1788
Published Date: 8 October 2014
Predictive performance of gentamicin dosing nomograms
Lee J, Yoon S, Shin D, Han H, An H, Lee J, Lim KS, Yu KS, Lee H
Drug Design, Development and Therapy 2014, 8:1097-1106
Published Date: 16 August 2014
Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state
Jang K, Yoon S, Kim SE, Cho JY, Yoon SH, Lim KS, Yu KS, Jang IJ, Lee H
Drug Design, Development and Therapy 2014, 8:851-858
Published Date: 25 June 2014
Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers
Yoon S, Lee H, Kim TE, Lee S, Chee DH, Cho JY, Yu KS, Jang IJ
Drug Design, Development and Therapy 2014, 8:123-128
Published Date: 15 January 2014